Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285727 · ClinicalTrials.gov registry record · NA
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00285727: Completed NA study, sponsored by Stanford University.
NCT00285727 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00285727, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other week for the remainder of the 8 weeks.
Interventions
- DRUG Ropinirole CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00285727
The ClinicalTrials.gov registry entry for NCT00285727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ropinirole CR is the first listed.
NCT00285727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00285727 about?
NCT00285727 is a clinical study titled "Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression". This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other we...
What is the current status of trial NCT00285727?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2006-01. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00285727?
The interventions under investigation include: Ropinirole CR (DRUG).
Who is sponsoring clinical trial NCT00285727?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.